Spotlight Asset Group’s Mustang Bio MBIO Stock Holding History

Spotlight Asset Group’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-407	Closed	-$138K	–	253
2023 Q1	$138K	Buy	+407	New	+$167K	0.14%	73
2022 Q3	$138K	Buy	+407	New	+$189K	0.14%	73
2021 Q3	$821K	Hold	407	–	–	0.41%	49
2021 Q2	$1.01M	Hold	407	–	–	0.39%	50
2021 Q1	$1.01M	Buy	407 +387	+1,935%	+$1.15M	0.38%	53
2020 Q4	$58K	Hold	20	–	–	0.02%	134
2020 Q3	$48K	Hold	20	–	–	0.02%	142
2020 Q2	$49K	Hold	20	–	–	0.02%	137
2020 Q1	$41K	Hold	20	–	–	0.02%	113
2019 Q4	$41K	Buy	+20	New	+$45.8K	0.02%	125

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Spotlight Asset Group's MBIO Position: Q2 2023 in Review

Spotlight Asset Group sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 407 shares — an estimated $138K sold.

Spotlight Asset Group first reported a position in MBIO in Q4 2019 and held it in 10 quarters. The position peaked at $1.01M in Q2 2021. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

Spotlight Asset Group reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
Spotlight Asset Group sold 407 Mustang Bio shares in Q2 2023, an estimated $138K.
Spotlight Asset Group first reported a position in Mustang Bio in Q4 2019 and held it in 10 quarters.
Spotlight Asset Group's Mustang Bio position peaked at $1.01M in Q2 2021.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Spotlight Asset Group's 13F filing for Q2 2023, filed 9 Aug 2023.